{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Breast cancer", "Invasion", "Migration", "Proliferation", "miR-1908-3p"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32650755", "DateCompleted": {"Year": "2021", "Month": "03", "Day": "10"}, "DateRevised": {"Year": "2021", "Month": "03", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "07", "Day": "10"}], "Language": ["eng"], "ELocationID": ["644", "10.1186/s12885-020-07125-4"], "Journal": {"ISSN": "1471-2407", "JournalIssue": {"Volume": "20", "Issue": "1", "PubDate": {"Year": "2020", "Month": "Jul", "Day": "10"}}, "Title": "BMC cancer", "ISOAbbreviation": "BMC Cancer"}, "ArticleTitle": "Evaluation of MiR-1908-3p as a novel serum biomarker for breast cancer and analysis its oncogenic function and target genes.", "Pagination": {"StartPage": "644", "MedlinePgn": "644"}, "Abstract": {"AbstractText": ["Breast cancer is one of the most common tumors for women globally. Various miRNAs have been reported to play a crucial role in breast cancer, however the clinical significance of miR-1908-3p in breast cancer remains unclear. The present study aimed to explore the role of miR-1908-3p in breast cancer.", "The expression of miR-1908-3p was detected in 50 pairs of breast cancer tissues and adjacent normal tissues, 60 breast cancer patient serum and 60 healthy volunteer serum. The functional roles of miR-1908-3p in breast cancer cells such as proliferation, migration and invasion were evaluated using CCK8, SRB, wound healing and transwell chambers. In addition, bioinformatics tools were used to identify potential targets of miR-1908-3p.", "The results showed that the expression of miR-1908-3p were increased in breast cancer tissues and serum compared with normal breast tissues and serum of healthy volunteers respectively. Furthermore, the young breast cancer patients and HER2-positive patients had a higher level of tissues' miR-1908-3p than elder breast cancer patients and HER2-negative patients, respectively. The young breast cancer patients had a higher level of serum miR-1908-3p than elder breast cancer patients, ROC analysis suggested that miR-1908-3p had the potential as a promising serum diagnostic biomarker of breast cancer. Up-regulation of miR-1908-3p promoted the cells proliferation, migration and invasion while knockdown of miR-1908-3p inhibited these processes in breast cancer cell MCF-7 and MDA-MB-231. The potential target genes of miR-1908-3p in breast cancer included ID4, LTBP4, GPM6B, RGMA, EFCAB1, ALX4, OSR1 and PPARA. Higher expression of these eight genes correlated with a better prognosis for breast cancer patients.", "These results suggest that miR-1908-3p may exert its oncogenic functions via suppression of these eight genes in breast cancer."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China."}], "LastName": "Zhu", "ForeName": "Youzhi", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, College of Life Sciences, Fujian Normal University, Fuzhou, China."}, {"Identifier": [], "Affiliation": "The Engineering Technology Research Center of Characteristic Medicinal Plants of Fujian, Ningde Normal University, Ningde, China."}], "LastName": "Wang", "ForeName": "Qingshui", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, College of Life Sciences, Fujian Normal University, Fuzhou, China."}], "LastName": "Xia", "ForeName": "Yun", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, College of Life Sciences, Fujian Normal University, Fuzhou, China."}], "LastName": "Xiong", "ForeName": "Xiaoxue", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, College of Life Sciences, Fujian Normal University, Fuzhou, China."}], "LastName": "Weng", "ForeName": "Shuyun", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, College of Life Sciences, Fujian Normal University, Fuzhou, China."}], "LastName": "Ni", "ForeName": "Huizhen", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, College of Life Sciences, Fujian Normal University, Fuzhou, China."}], "LastName": "Ye", "ForeName": "Yan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China."}], "LastName": "Chen", "ForeName": "Ling", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China."}], "LastName": "Lin", "ForeName": "Junyu", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, College of Life Sciences, Fujian Normal University, Fuzhou, China."}], "LastName": "Chen", "ForeName": "Yajuan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, College of Life Sciences, Fujian Normal University, Fuzhou, China."}], "LastName": "Niu", "ForeName": "Haitao", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China. rjbhcxj@fjmu.edu.cn."}], "LastName": "Chen", "ForeName": "Xiangjin", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, College of Life Sciences, Fujian Normal University, Fuzhou, China. yaolin@fjnu.edu.cn."}], "LastName": "Lin", "ForeName": "Yao", "Initials": "Y"}], "GrantList": [{"GrantID": "2016YFE0121900", "Agency": "International S&T Cooperation Program of China", "Country": ""}, {"GrantID": "2017Y9089", "Agency": "Science and technology innovation joint fund project", "Country": ""}, {"GrantID": "2019-ZQN-63", "Agency": "Training plan for young and middle-aged key talents", "Country": ""}, {"GrantID": "2018J01723", "Agency": "Natural Science Foundation of Fujian Province", "Country": ""}, {"GrantID": "2019J01278", "Agency": "Natural Science Foundation of Fujian Province", "Country": ""}, {"GrantID": "WKJ2016-2-27", "Agency": "United Fujian Provincial Health and Education Project for Tackling the Key Research", "Country": ""}, {"GrantID": "PP201904", "Agency": "The Engineering Technology Research Center of Characteristic Medicinal Plans of Fujian", "Country": ""}, {"GrantID": "IRTL1702", "Agency": "scientific research innovation team construction program of Fujian Normal University", "Country": ""}], "PublicationTypeList": ["Evaluation Study", "Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Cancer", "NlmUniqueID": "100967800", "ISSNLinking": "1471-2407"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biomarkers, Tumor"}, {"RegistryNumber": "0", "NameOfSubstance": "MIRN1908 microRNA, human"}, {"RegistryNumber": "0", "NameOfSubstance": "MicroRNAs"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Aged, 80 and over"}, {"QualifierName": ["genetics"], "DescriptorName": "Biomarkers, Tumor"}, {"QualifierName": ["genetics", "metabolism", "pathology"], "DescriptorName": "Breast Neoplasms"}, {"QualifierName": ["genetics", "metabolism", "pathology"], "DescriptorName": "Carcinogenesis"}, {"QualifierName": [], "DescriptorName": "Case-Control Studies"}, {"QualifierName": [], "DescriptorName": "Cell Movement"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Follow-Up Studies"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["genetics"], "DescriptorName": "MicroRNAs"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": [], "DescriptorName": "Neoplasm Metastasis"}, {"QualifierName": [], "DescriptorName": "Prognosis"}, {"QualifierName": [], "DescriptorName": "Tumor Cells, Cultured"}], "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424. doi: 10.3322/caac.21492.", "ArticleIdList": ["10.3322/caac.21492", "30207593"]}, {"Citation": "van den Berg M, Krauskopf J, Ramaekers J, Kleinjans J, Prickaerts J, Bried\u00e9 J. Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders. Prog Neurobiol. 2019;185:101732. doi: 10.1016/j.pneurobio.2019.101732.", "ArticleIdList": ["10.1016/j.pneurobio.2019.101732", "31816349"]}, {"Citation": "Lou W, Fan W. Construction of potential glioblastoma multiforme-related miRNA-mRNA regulatory network. Front Mol Neurosci. 2019;12:66. doi: 10.3389/fnmol.2019.00066.", "ArticleIdList": ["10.3389/fnmol.2019.00066", "PMC6444190", "30971889"]}, {"Citation": "Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, Liu S. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One. 2010;5:e13735. doi: 10.1371/journal.pone.0013735.", "ArticleIdList": ["10.1371/journal.pone.0013735", "PMC2966402", "21060830"]}, {"Citation": "Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A, Hein A. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. PLoS One. 2012;7:e29770. doi: 10.1371/journal.pone.0029770.", "ArticleIdList": ["10.1371/journal.pone.0029770", "PMC3252341", "22242178"]}, {"Citation": "Shimomura A, Shiino S, Kawauchi J, Takizawa S, Sakamoto H, Matsuzaki J, Ono M, Takeshita F, Niida S, Shimizu C. Novel combination of serum microRNA for detecting breast cancer in the early stage. Cancer Sci. 2016;107:326\u2013334. doi: 10.1111/cas.12880.", "ArticleIdList": ["10.1111/cas.12880", "PMC4814263", "26749252"]}, {"Citation": "Wang X, Fang L. Advances in circular RNAs and their roles in breast cancer. J Exp Clin Cancer Res. 2018;37:206. doi: 10.1186/s13046-018-0870-8.", "ArticleIdList": ["10.1186/s13046-018-0870-8", "PMC6116371", "30157902"]}, {"Citation": "Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215\u2013233. doi: 10.1016/j.cell.2009.01.002.", "ArticleIdList": ["10.1016/j.cell.2009.01.002", "PMC3794896", "19167326"]}, {"Citation": "Yan R, Yang T, Zhai H, Zhou Z, Gao L, Li Y. MicroRNA-150-5p affects cell proliferation, apoptosis, and EMT by regulation of the BRAFV600E mutation in papillary thyroid cancer cells. J Cell Biochem. 2018;119:8763\u20138772. doi: 10.1002/jcb.27108.", "ArticleIdList": ["10.1002/jcb.27108", "30126001"]}, {"Citation": "Yang Z, Zhang T, Wang Q, Gao H. Overexpression of microRNA-34a attenuates proliferation and induces apoptosis in pituitary adenoma cells via SOX7. Mol Ther Oncolytics. 2018;10:40\u201347. doi: 10.1016/j.omto.2018.07.001.", "ArticleIdList": ["10.1016/j.omto.2018.07.001", "PMC6083820", "30109259"]}, {"Citation": "Li P, Xie X-B, Chen Q, Pang G-L, Luo W, Tu J-C, Zheng F, Liu S-M, Han L, Zhang J-K. MiRNA-15a mediates cell cycle arrest and potentiates apoptosis in breast cancer cells by targeting synuclein-gamma. Asian Pac J Cancer Prev. 2014;15:6949\u20136954. doi: 10.7314/APJCP.2014.15.16.6949.", "ArticleIdList": ["10.7314/APJCP.2014.15.16.6949", "25169552"]}, {"Citation": "Xiao R, Li C, Chai B. miRNA-144 suppresses proliferation and migration of colorectal cancer cells through GSPT1. Biomed Pharmacother. 2015;74:138\u2013144. doi: 10.1016/j.biopha.2015.08.006.", "ArticleIdList": ["10.1016/j.biopha.2015.08.006", "26349975"]}, {"Citation": "Carreras-Badosa G, Bonmat\u00ed A, Ortega F-J, Mercader J-M, Guindo-Mart\u00ednez M, Torrents D, Prats-Puig A, Martinez-Calcerrada J-M, Platero-Gutierrez E, De Zegher F. Altered circulating miRNA expression profile in pregestational and gestational obesity. J Clin Endocrinol Metab. 2015;100:E1446\u2013E1456. doi: 10.1210/jc.2015-2872.", "ArticleIdList": ["10.1210/jc.2015-2872", "26406295"]}, {"Citation": "Trionfini P, Benigni A, Remuzzi G. MicroRNAs in kidney physiology and disease. Nat Rev Nephrol. 2015;11:23. doi: 10.1038/nrneph.2014.202.", "ArticleIdList": ["10.1038/nrneph.2014.202", "25385286"]}, {"Citation": "Mao Y, Wei F, Wei C, Wei C. microRNA-574 inhibits cell proliferation and invasion in glioblastoma multiforme by directly targeting zinc finger E-box-binding homeobox 1. Mol Med Rep. 2018;18:1826\u20131834.", "ArticleIdList": ["29901177"]}, {"Citation": "Xia X, Li Y, Wang W, Tang F, Tan J, Sun L, Li Q, Sun L, Tang B, He S. MicroRNA-1908 functions as a glioblastoma oncogene by suppressing PTEN tumor suppressor pathway. Mol Cancer. 2015;14:154. doi: 10.1186/s12943-015-0423-0.", "ArticleIdList": ["10.1186/s12943-015-0423-0", "PMC4534015", "26265437"]}, {"Citation": "Lian D, Wang Z, Liu N. MicroRNA-1908 is a biomarker for poor prognosis in human osteosarcoma. Eur Rev Med Pharmacol Sci. 2016;20:1258\u20131262.", "ArticleIdList": ["27097944"]}, {"Citation": "Jin J-C, Jin X-L, Zhang X, Piao Y-S, Liu S-P. Effect of OSW-1 on microRNA expression profiles of hepatoma cells and functions of novel microRNAs. Mol Med Rep. 2013;7:1831\u20131837. doi: 10.3892/mmr.2013.1428.", "ArticleIdList": ["10.3892/mmr.2013.1428", "23588479"]}, {"Citation": "Chai Z, Fan H, Li Y, Song L, Jin X, Yu J, Li Y, Ma C, Zhou R. miR-1908 as a novel prognosis marker of glioma via promoting malignant phenotype and modulating SPRY4/RAF1 axis. Oncol Rep. 2017;38:2717\u20132726. doi: 10.3892/or.2017.6003.", "ArticleIdList": ["10.3892/or.2017.6003", "PMC5780024", "29048686"]}, {"Citation": "HAIQIU & LIAO microRNA-32 induces radioresistance by targeting DAB2IP and regulating autophagy in prostate cancer cells. Oncol Lett. 2015;10:2055. doi: 10.3892/ol.2015.3551.", "ArticleIdList": ["10.3892/ol.2015.3551", "PMC4579868", "26622795"]}, {"Citation": "Kim S, Woo SM, Min K-J, Seo SU. WP1130 enhances TRAIL-induced apoptosis through USP9X-dependent miR-708-mediated downregulation of c-FLIP. Cancers. 2019;11:344. doi: 10.3390/cancers11030344.", "ArticleIdList": ["10.3390/cancers11030344", "PMC6469024", "30862047"]}, {"Citation": "Zhang L, Li X, Lin X, Wu M. Nerve growth factor promotes the proliferation of M\u00fcller cells co-cultured with internal limiting membrane by regulating cell cycle via Trk-A/PI3K/Akt pathway. BMC Ophthalmol. 2019;19:1. doi: 10.1186/s12886-018-1008-7.", "ArticleIdList": ["10.1186/s12886-018-1008-7", "PMC6580575", "31208396"]}, {"Citation": "Agarwal V, Bell GW, Nam J-W, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. elife. 2015;4:e05005. doi: 10.7554/eLife.05005.", "ArticleIdList": ["10.7554/eLife.05005", "PMC4532895", "26267216"]}, {"Citation": "Garcia DM, Baek D, Shin C, Bell GW, Grimson A, Bartel DP. Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat Struct Mol Biol. 2011;18:1139. doi: 10.1038/nsmb.2115.", "ArticleIdList": ["10.1038/nsmb.2115", "PMC3190056", "21909094"]}, {"Citation": "Grimson A, Farh KK-H, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell. 2007;27:91\u2013105. doi: 10.1016/j.molcel.2007.06.017.", "ArticleIdList": ["10.1016/j.molcel.2007.06.017", "PMC3800283", "17612493"]}, {"Citation": "Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15\u201320. doi: 10.1016/j.cell.2004.12.035.", "ArticleIdList": ["10.1016/j.cell.2004.12.035", "15652477"]}, {"Citation": "Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98\u2013W102. doi: 10.1093/nar/gkx247.", "ArticleIdList": ["10.1093/nar/gkx247", "PMC5570223", "28407145"]}, {"Citation": "Nagy \u00c1, L\u00e1nczky A, Menyh\u00e1rt O, Gy\u0151rffy B. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep. 2018;8:9227. doi: 10.1038/s41598-018-27521-y.", "ArticleIdList": ["10.1038/s41598-018-27521-y", "PMC6003936", "29907753"]}, {"Citation": "Dell\u2019Orso S, Ganci F, Strano S, Blandino G, Fontemaggi G. ID4: a new player in the cancer arena. Oncotarget. 2010;1:48. doi: 10.18632/oncotarget.108.", "ArticleIdList": ["10.18632/oncotarget.108", "PMC4053547", "21293053"]}, {"Citation": "Mauel S, Kruse B, Etschmann B, von der Schulenburg AG, Schaerig M, St\u00f6vesand K, Wilcken B, Sterner-kock A. Latent transforming growth factor binding protein 4 (LTBP-4) is downregulated in human mammary adenocarcinomas in vitro and in vivo. Apmis. 2007;115:687\u2013700. doi: 10.1111/j.1600-0463.2007.apm_453.x.", "ArticleIdList": ["10.1111/j.1600-0463.2007.apm_453.x", "17550376"]}, {"Citation": "Lu Y, Li Y, Wang Z, Xie S, Wang Q, Lei X, Ruan Y, Li J. Downregulation of RGMA by HIF-1A/miR-210-3p axis promotes cell proliferation in oral squamous cell carcinoma. Biomed Pharmacother. 2019;112:108608. doi: 10.1016/j.biopha.2019.108608.", "ArticleIdList": ["10.1016/j.biopha.2019.108608", "30798120"]}, {"Citation": "Yang J, Han F, Liu W, Chen H, Hao X, Jiang X, Yin L, Huang Y, Cao J, Zhang H. ALX4, an epigenetically down regulated tumor suppressor, inhibits breast cancer progression by interfering Wnt/\u03b2-catenin pathway. J Exp Clin Cancer Res. 2017;36:170. doi: 10.1186/s13046-017-0643-9.", "ArticleIdList": ["10.1186/s13046-017-0643-9", "PMC5706407", "29183346"]}, {"Citation": "Zhang Y, Yuan Y, Liang P, Guo X, Ying Y, Shu X-S, Gao M, Cheng Y. OSR1 is a novel epigenetic silenced tumor suppressor regulating invasion and proliferation in renal cell carcinoma. Oncotarget. 2017;8:30008. doi: 10.18632/oncotarget.15611.", "ArticleIdList": ["10.18632/oncotarget.15611", "PMC5444721", "28404905"]}, {"Citation": "Cai K, Li T, Guo L, Guo H, Zhu W, Yan L, Li F. Long non-coding RNA LINC00467 regulates hepatocellular carcinoma progression by modulating miR-9-5p/PPARA expression. Open Biol. 2019;9:190074. doi: 10.1098/rsob.190074.", "ArticleIdList": ["10.1098/rsob.190074", "PMC6769294", "31480990"]}]}], "History": [{"Year": "2020", "Month": "2", "Day": "18"}, {"Year": "2020", "Month": "7", "Day": "1"}, {"Year": "2020", "Month": "7", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "10"}], "PublicationStatus": "epublish", "ArticleIdList": ["32650755", "PMC7350204", "10.1186/s12885-020-07125-4", "10.1186/s12885-020-07125-4"]}}]}